PMV Pharmaceuticals
$1.1950
12
+$0.02+1.27% 14:41 Today
Statistics
Day High
1.21
Day Low
1.17
52W High
1.88
52W Low
0.964
Volume
75,542
Avg. Volume
382,845
Mkt Cap
63.59M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6AugExpected
Expected EPS
-0.4
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-117.42MNet Income
Analyst Ratings
5.00Average Price Target
The highest estimate is 5.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PMVP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.33B
Intellia Therapeutics
NTLA
Mkt Cap2.19B
Editas Medicine
EDIT
Mkt Cap412.81M
Beam Therapeutics
BEAM
Mkt Cap3.51B
Allogene Therapeutics
ALLO
Mkt Cap690.31M
Sangamo Therapeutics
SGMO
Mkt Cap70.43M
Fate Therapeutics
FATE
Mkt Cap243.61M
Gilead Sciences
GILD
Mkt Cap153.66B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.57B
About
PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations. Originally known as PJ Pharmaceuticals, Inc., the firm rebranded to PMV Pharmaceuticals, Inc. in July 2013. The company was founded in 2013 and has its main operational base in Cranbury, New Jersey.
Show more...
CEO
Dr. David H. Mack Ph.D.
Employees
47
Country
United States
ISIN
US69353Y1038
Listings
0 Comments
Share your thoughts
FAQ
What is PMV Pharmaceuticals stock price today?▼
The current price of PMVP is $1.20 USD — it has increased by +1.27% in the past 24 hours. Watch PMV Pharmaceuticals stock price performance more closely on the chart.
What is PMV Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PMV Pharmaceuticals stocks are traded under the ticker PMVP.
Is PMV Pharmaceuticals stock price growing?▼
PMVP stock has risen by +6.64% compared to the previous week, the month change is a -4.37% fall, over the last year PMV Pharmaceuticals has showed a +10.55% increase.
What is PMV Pharmaceuticals market cap?▼
Today PMV Pharmaceuticals has the market capitalization of 63.59M
When is the next PMV Pharmaceuticals earnings date?▼
PMV Pharmaceuticals is going to release the next earnings report on August 06, 2026.
What were PMV Pharmaceuticals earnings last quarter?▼
PMVP earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.41 USD resulting in a +17.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is PMV Pharmaceuticals revenue for the last year?▼
PMV Pharmaceuticals revenue for the last year amounts to 0 USD.
What is PMV Pharmaceuticals net income for the last year?▼
PMVP net income for the last year is -117.42M USD.
How many employees does PMV Pharmaceuticals have?▼
As of June 25, 2026, the company has 47 employees.
In which sector is PMV Pharmaceuticals located?▼
PMV Pharmaceuticals operates in the Health & Wellness sector.
When did PMV Pharmaceuticals complete a stock split?▼
PMV Pharmaceuticals has not had any recent stock splits.
Where is PMV Pharmaceuticals headquartered?▼
PMV Pharmaceuticals is headquartered in Princeton, United States.